Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence

de Boer and colleagues present a cost-effectiveness analysis based in the Netherlands of two vaccines available for the prevention of herpes zoster. Zostavax® was the first vaccine available for the prevention…